Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProTECT III: Progesterone for TBI
NCT00822900Phase 3Terminated
- Start
- Mar 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of progesterone in traumatic brain injury (TBI). Started Mar 2010; status: terminated.
02
Drugs
progesterone
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00822900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822900.